 |
N.B. Unless otherwise stated in the footnotes below, each coloured box represents one dose of HPV vaccine. |
|
(1) |
Human papilloma virus vaccination is given in three doses from the age of 9 years onwards and is particularly recommended to females. The vaccination regimen is according to specifications of the type of vaccine used. |
(2) |
HPV vaccine (against papilloma viruses 6, 11, 16, 18) is recommended to all 14 years old females and given as a three dose regime at a 0-2-6 month schedule. |
(3) |
Recommended for females and given as a three dose regime at a 0-2-6 month schedule. |
(4) |
Recommended for females only with a catch-up programme up the age of 18 years. |
(5) |
HPV is recommended to a single cohort of girls between the age of 11-14 depending on the Autonomous Regions. Date of introduction of the vaccine may vary between the Autonomous Regions. |
(6) |
Recommended to female adolescents, with three doses given at 0, 1-2 and 6 months. Catch-up for 15-19 years old during 5 years (since 2008). |
|
This overview is derived from national childhood vaccination schedules as provided to EUVAC.NET. More information is obtained from individual national schedules.
|
|
